Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × Glucose × Clear all

Phase

Phase NA 6 Phase 3 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Cancer Pain 1

Interventions

Fluorouracil 20 Cisplatin 20 Gemcitabine 15 Radiotherapy 14 Oxaliplatin 14 Paclitaxel 13 Docetaxel 13 Carboplatin 12 Bevacizumab 12 Leucovorin 11 Cyclophosphamide 11 Capecitabine 11 Drug Therapy 10 Irinotecan 9 Cytarabine 9 Magnetic Resonance Spectroscopy 7 Dexamethasone 7 Saline Solution 6 Rituximab 6 Nivolumab 6 Methotrexate 6 Letrozole 6 Exercise 6 Etoposide 6 pembrolizumab 5 Melphalan 5 Lidocaine 5 Filgrastim 5 Electroporation 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡